A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

A task force of law enforcement officials in Louisiana was able to confiscate thousands of pain pills after information was ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.